RBC Europe’s VolitionRx Ltd VNRX Stock Holding History

RBC Europe’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-444	Closed	-$27.5K	–	1147
2021 Q3	$27.5K	Hold	444	–	–	﹤0.01%	710
2021 Q2	$29.2K	Hold	444	–	–	﹤0.01%	721
2021 Q1	$33.6K	Buy	444 +115	+35%	+$9.86K	﹤0.01%	644
2020 Q4	$25.6K	Hold	329	–	–	﹤0.01%	656
2020 Q3	$21.1K	Hold	329	–	–	﹤0.01%	639
2020 Q2	$25.6K	Hold	329	–	–	﹤0.01%	576
2020 Q1	$20.4K	Hold	329	–	–	﹤0.01%	553
2019 Q4	$31.2K	Hold	329	–	–	﹤0.01%	556
2019 Q3	$37K	Hold	329	–	–	﹤0.01%	502
2019 Q2	$20.6K	Hold	329	–	–	﹤0.01%	649
2019 Q1	$21.4K	Hold	329	–	–	﹤0.01%	637
2018 Q4	$11.9K	Hold	329	–	–	﹤0.01%	747
2018 Q3	$17K	Hold	329	–	–	﹤0.01%	715
2018 Q2	$13.2K	Hold	329	–	–	﹤0.01%	785
2018 Q1	$15.8K	Hold	329	–	–	﹤0.01%	722
2017 Q4	$19.3K	Hold	329	–	–	﹤0.01%	685
2017 Q3	$17.3K	Buy	+329	New	+$19.3K	﹤0.01%	718

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RBC Europe's VNRX Position: Q4 2021 in Review

RBC Europe sold out of VolitionRx Ltd (VNRX) in Q4 2021, closing a stake of 444 shares — an estimated $27.5K sold.

RBC Europe first reported a position in VNRX in Q3 2017 and held it in 17 quarters. The position peaked at $37K in Q3 2019. 36 funds tracked by Wall St. Rank hold VNRX as of Q4 2021.

RBC Europe reported no remaining VolitionRx Ltd position as of Q4 2021 after selling out during the quarter.
RBC Europe sold 444 VolitionRx Ltd shares in Q4 2021, an estimated $27.5K.
RBC Europe first reported a position in VolitionRx Ltd in Q3 2017 and held it in 17 quarters.
RBC Europe's VolitionRx Ltd position peaked at $37K in Q3 2019.
36 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.